Personalized test tracks cancer relapse

Alberto Bardelli ()
Additional contact information
Alberto Bardelli: University of Torino

Nature, 2017, vol. 545, issue 7655, 417-418

Abstract: Genomic analysis of lung-tumour evolution has been used to create personalized blood tests that enable successful clinical monitoring for early signs of cancer relapse — a promising step on the road to precision medicine. See Article p.446

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/545417a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:545:y:2017:i:7655:d:10.1038_545417a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/545417a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().